Conclusion: All antidepressants were more efficacious than placebo in adults with major depressive disorder. Smaller differences between active drugs were found when placebo-controlled trials were included in the analysis, whereas there was more variability in efficacy and acceptability in head-to-head trials. These results should serve evidence-based practice and inform patients, physicians, guideline developers, and policy makers on the relative merits of the different antidepressants.
PubMed 29477251 ↗Mirtazapine
Also known as Remeron
The short answer. People are split on Mirtazapine — 52% of 58 say it helped. It is most often used for sleep: 86% of 37 reports say that improved. It is well studied — 174 meta-analyses on PubMed. The most common complaint is drowsiness.
From 93 mentions in total — the rest didn't say how it went and aren't counted.
What Mirtazapine does, according to users
Of the people who reported each effect, the share who said it got better.
3 more with fewer than 3 reports
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
3+ meta-analyses or systematic reviews and 10+ randomized controlled trials in humans. The grade measures how much human research exists — read the conclusions below for what it found. 174 meta-analyses on PubMed ↗ · 262 randomized trials ↗
Conclusion: This NMA suggests a superiority of the regulatory approved adjunctive atypical antipsychotics, thyroid hormones, dopamine compounds (modafinil and lisdexamfetamine) and lithium. Acceptability was lower with ziprasidone, mirtazapine, and cariprazine. Further research and head-to-head studies should be considered to strengthen the best available options for TRD.
PubMed 34986373 ↗Conclusion: To our knowledge, this is the largest contemporary review of pharmacological agents for the treatment of generalised anxiety disorder by use of network analysis. There are several effective treatment choices for generalised anxiety disorder across classes of medication. The failure of initial pharmacological therapy might not be a reason to abandon a pharmacological treatment strategy.
PubMed 30712879 ↗Conclusion: This review found low to moderate certainty evidence supporting the interaction between warfarin and a small group of medications, which result in increased bleeding risk. PPIs are associated with reduced hospitalization for upper GI bleeding for patients taking warfarin. Further studies are required to better understand drug-drug interactions leading to thromboembolic outcomes or death.
PubMed 33769581 ↗143 human trials on ClinicalTrials.gov test Mirtazapine — 87 completed, 7 recruiting now. See all on ClinicalTrials.gov ↗
- Treating Negative Affect in Low Back Pain Patients · Chronic Low Back Pain, Negative Affectivity · 2024
- Trial of Mirtazapine for Depression in IBD · Major Depressive Disorder, Inflammatory Bowel Diseases · 2025
- Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP) · Elderly, Major Depression · 2020
What government agencies say
Official records from US, Canadian and EU regulators, each linked to its source.
Boxed warning (the FDA's strongest label warning): “SUICIDAL THOUGHTS AND BEHAVIORS Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors.…”
8 recalls of products named for Mirtazapine. Most recent:
- 2020-04-22 · Class II: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed record ↗
- 2019-12-18 · Class I: Labeling: Label Error on Declared Strength; cases labelled Mirtazapine 15mg tablets, 500-count bottles, contain 500-count bottles of Mirtazapine 15mg… record ↗
- 2017-03-15 · Class II: Presence of Foreign Tablets/Capsules; possibility of Glipizide 10 mg tablet in bottle record ↗
Class I = could cause serious harm; Class II = temporary or reversible harm; Class III = unlikely to cause harm. Recalls are of specific products and lots, not of the ingredient itself. All recalls (openFDA) ↗
91,057 adverse-event reports mention Mirtazapine. Most often reported:
- Nausea · 5,028
- Fatigue · 4,904
- Drug ineffective · 4,786
- Fall · 4,168
- Diarrhoea · 4,111
- Off label use · 3,999
Reports often involve several drugs and serious illness; a report doesn't prove the drug caused the problem, and these counts can't tell you how often it happens. Source query (openFDA) ↗
LiverTox rates Mirtazapine C — a probable rare cause of liver injury (3–12 published cases). LiverTox entry ↗
NIH has funded 6 research projects with Mirtazapine in the title, $10,431,380 in total (1998–2021). NIH RePORTER ↗
Plain-language guides from the US government: MedlinePlus: Mirtazapine ↗
Dosage people report
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“Mirtazapine worked great for me, I'd credit it with saving my life.”
“The only drugs that has helped at all so far have been Buspar and Remeron, both of which eventually stopped working for me.”
“The only one that really helped me was mirtazapine but I piled on the weight.”
“A med like Remeron (I had HORRIBLE side effects) uses several of my mutated/broken metabolizers.”
Top discussions (5)
- What is something that ''cured'' your insomnia like magic? ↗
- For people who managed to get out of the physical and mental debilitating cycles of depression/grief. ↗
- Desperate for help, terrible insomnia ↗
- Prolonged Remission of Major Depressive Disorder After Single Nitrous Oxide [laughing gas] Inhalation Treatment | 1h long inhalation dropped depression scale to 0 and lasted for >1 month ↗
- I was permanently and severely damaged by a medication I took in 2019. ↗
Other options for sleep
Sources
- User reports: 93 mentions in public discussions, quoted with a link to each discussion (e.g. this thread ↗).
- PubMed (US National Library of Medicine, NIH): meta-analyses ↗ · randomized trials ↗
- ClinicalTrials.gov (NIH): registered trials ↗
- FDA drug label (DailyMed) ↗
- FDA adverse-event reports (FAERS) ↗
- FDA recalls ↗
- LiverTox (NIH) ↗
- MedlinePlus (NIH) ↗
- NIH RePORTER ↗
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 5, 2026. How we rate